EAM
IBB icon

Evanson Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Evanson Asset Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,827
Closed -$576K – 284
2021
Q1 		$576K Sell
3,827
-105
-3% -$16.7K 0.09% 146
2020
Q4 		$596K Buy
3,932
+170
+5% +$24.3K 0.09% 134
2020
Q3 		$509K Buy
3,762
+35
+0.9% +$4.75K 0.09% 126
2020
Q2 		$509K Hold
3,727
– – 0.1% 117
2020
Q1 		$402K Buy
3,727
+100
+3% +$11.5K 0.1% 129
2019
Q4 		$437K Hold
3,627
– – 0.09% 140
2019
Q3 		$361K Hold
3,627
– – 0.07% 154
2019
Q2 		$396K Hold
3,627
– – 0.08% 148
2019
Q1 		$405K Hold
3,627
– – 0.08% 142
2018
Q4 		$350K Hold
3,627
– – 0.08% 149
2018
Q3 		$442K Sell
3,627
-12
-0.3% -$1.41K 0.09% 138
2018
Q2 		$400K Buy
3,639
+12
+0.3% +$1.28K 0.08% 153
2018
Q1 		$387K Sell
3,627
-75
-2% -$8.31K 0.08% 159
2017
Q4 		$395K Sell
3,702
-27
-0.7% -$2.89K 0.08% 158
2017
Q3 		$415K Buy
3,729
+327
+10% +$35K 0.09% 138
2017
Q2 		$352K Hold
3,402
– – 0.08% 148
2017
Q1 		$333K Sell
3,402
-1,125
-25% -$108K 0.08% 149
2016
Q4 		$400K Hold
4,527
– – 0.11% 133
2016
Q3 		$437K Hold
4,527
– – 0.12% 113
2016
Q2 		$388K Hold
4,527
– – 0.12% 129
2016
Q1 		$394K Hold
4,527
– – 0.13% 118
2015
Q4 		$511K Hold
4,527
– – 0.19% 95
2015
Q3 		$458K Hold
4,527
– – 0.17% 106
2015
Q2 		$557K Hold
4,527
– – 0.19% 98
2015
Q1 		$518K Sell
4,527
-60
-1% -$6.62K 0.19% 102
2014
Q4 		$464K Buy
4,587
+60
+1% +$5.83K 0.17% 106
2014
Q3 		$413K Sell
4,527
-750
-14% -$65.8K 0.17% 112
2014
Q2 		$452K Buy
+5,277
New +$416K 0.17% 113

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Evanson Asset Management's IBB Position: Q2 2021 in Review

Evanson Asset Management sold out of iShares Biotechnology ETF (IBB) in Q2 2021, closing a stake of 3,827 shares — an estimated $576K sold.

Evanson Asset Management first reported a position in IBB in Q2 2014 and held it in 28 quarters. The position peaked at $596K in Q4 2020. 864 funds tracked by Wall St. Rank hold IBB as of Q2 2021.

  • Evanson Asset Management reported no remaining iShares Biotechnology ETF position as of Q2 2021 after selling out during the quarter.
  • Evanson Asset Management sold 3,827 iShares Biotechnology ETF shares in Q2 2021, an estimated $576K.
  • Evanson Asset Management first reported a position in iShares Biotechnology ETF in Q2 2014 and held it in 28 quarters.
  • Evanson Asset Management's iShares Biotechnology ETF position peaked at $596K in Q4 2020.
  • 864 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2021.

Based on Evanson Asset Management's 13F filing for Q2 2021, filed 14 Jul 2021.